Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Good safety profile reported for C31G vaginal gel in healthy volunteers

Dec. 1, 2004

Positive preliminary results from phase I/II study of PA-457

Nov. 25, 2004

Enrollment completed in phase II lipodystrophy study of EG-005

Nov. 25, 2004

Long-term antiviral activity of TMC-125 seen in HIV-infected patients

Nov. 24, 2004

TMC-114 active against resistant HIV-1

Nov. 24, 2004

Pharmacokinetic interactions with UK-427857 studied

Nov. 24, 2004

Positive opinion for Truvada in Europe

Nov. 22, 2004

VivaGel well tolerated in phase I study

Nov. 19, 2004

Six-year benefits of lopinavir/ritonavir therapy in HIV-infected patients

Nov. 17, 2004

Molecular cloaking technology enhances development of HIV-1 entry inhibitors

Nov. 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...